This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations by Inventor Mohamed Kamal
Introduction
Mohamed Kamal is an accomplished inventor based in Demarest, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of atopic dermatitis. His innovative approach has garnered attention in the pharmaceutical industry.
Latest Patents
Kamal holds a patent for "Methods for treating atopic dermatitis by administering an IL-4R antagonist antibody." This patent outlines methods for treating moderate-to-severe or severe atopic dermatitis in pediatric subjects. The methods involve administering one or more doses of an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or an antigen-binding fragment thereof.
Career Highlights
Kamal is currently associated with Regeneron Pharmaceuticals, Inc., where he applies his expertise in developing innovative treatments. His work focuses on advancing therapeutic options for patients suffering from atopic dermatitis.
Collaborations
Some of his notable coworkers include Ashish Bansal and Neil John Graham. Their collaborative efforts contribute to the ongoing research and development initiatives at Regeneron Pharmaceuticals.
Conclusion
Mohamed Kamal's contributions to the field of medicine through his patent and work at Regeneron Pharmaceuticals highlight his commitment to improving patient care. His innovative methods for treating atopic dermatitis represent a significant advancement in therapeutic options.